Search

everythinglearnresearchcommunity

for

Search:↓

Injecting vitamin D3 into the skin is an effective treatment for patchy hair loss.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

CAR is a useful marker for assessing alopecia areata severity.

General practitioners in Qassim have satisfactory knowledge of alopecia areata but need more education to address gaps and misconceptions.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

Betamethasone is more effective for hair regrowth than latanoprost but has more side effects.

People with alopecia who are more resilient tend to feel less stressed.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Alopecia areata may be linked to heart issues.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

PRP is more effective than Minoxidil for treating alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Corticosteroids regrow hair better and faster than pentoxifylline for alopecia areata.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

Betamethasone dipropionate lotion is more effective than minoxidil solution for treating Alopecia Areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.